GlassScriptPhysician profile
Alan M Greenberg
NPI 1043212707
$14,420.72
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,878 · 2020: $5,323 · 2021: $40.49 · 2022: $41.03 · 2023: $108 · 2024: $29.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $138.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $137.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acessa Health INC. | $9,462.20 | 2019-2020 | |
| Apyx Medical Corporation | $4,175.05 | 2019 | |
| Allergan, INC. | $204.47 | 2019-2022 | |
| Abbvie INC. | $149.72 | 2019-2024 | |
| Coopersurgical, INC. | $125.00 | 2019 | |
| Merck Sharp & Dohme LLC | $104.06 | 2019 | |
| Pfizer INC. | $80.15 | 2019-2020 | |
| Abbott Laboratories | $24.03 | 2019 | |
| Daiichi Sankyo INC. | $18.60 | 2019 | |
| Covidien LP | $18.43 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.01 | 2019 | |
| Vertical Pharmaceuticals, LLC | $14.99 | 2019 | |
| Ethicon US, LLC | $14.04 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $13.97 | 2023 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Greenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.